Carole Ben-Maimon's Net Worth
$1.25 Million
Who is Carole Ben-Maimon?
Carole Ben-Maimon has an estimated net worth of $1.25 Million. This is based on reported shares across multiple companies, which include Teligent, Inc., Larimar Therapeutics, Inc., and IMPAX LABORATORIES INC.
SEC CIK
Carole Ben-Maimon's CIK is 0001529611
Past Insider Trading and Trends
2019 was Carole Ben-Maimon's most active year for acquiring shares with 6 total transactions. Carole Ben-Maimon's most active month to acquire stocks was the month of April. 2013 was Carole Ben-Maimon's most active year for disposing of shares, totalling 3 transactions. Carole Ben-Maimon's most active month to dispose stocks was the month of September. 2013 saw Carole Ben-Maimon paying a total of $227,462.88 for 88,816 shares, this is the most they've acquired in one year. In 2012 Carole Ben-Maimon cashed out on 1,836 shares for a total of $44,688.24, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Teligent, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 1
| |||
Form 4
| +166.67% | 10K |
$0.59 | $5,885.00 | 16K |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
| +500.00% | 5K |
$3.48 | $17,408.56 | 6K |
Nov 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Larimar Therapeutics, Inc. (LRMR) Snapshot price: $5.87
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +24.78% | 66.13K |
—
|
—
| 332.95K |
Jan 17
| |||
Form 4
| +1.91% | 5K |
$3.71 | $18,525.00 | 266.83K |
May 17
| |||
Form 4
| +360.73% | 205K |
—
|
—
| 261.83K |
Jan 31
| |||
Form 4
| +126.56% | 31.75K |
$3.15 | $99,999.90 | 56.83K |
Sep 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 29
| |||
Form 4
|
∞
| 25.08K |
—
|
—
| 25.08K |
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPAX LABORATORIES INC No price found
President, Global Pharm.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +36.56% | 23K |
—
|
—
| 85.91K |
May 14
| |||
Form 4
| +11.99% | 6.73K |
$18.93 | $127,474.62 | 62.91K |
Oct 25
| |||
Form 4
| +10.38% | 5.28K |
$18.93 | $99,988.26 | 56.18K |
Oct 10
| |||
Form 4
| -0.78% | -399.00 |
$18.60 | -$7,421.40 | 50.9K |
May 23
| |||
Form 4
| +93.60% | 24.8K |
—
|
—
| 51.3K |
May 15
| |||
Form 4
| -6.48% | -1.84K |
$24.34 | -$44,688.24 | 26.5K |
Oct 28
| |||
Form 4
| +18.05% | 4.33K |
—
|
—
| 28.33K |
May 23
| |||
Form 4
|
∞
| 24K |
—
|
—
| 24K |
Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||